Transit-1: Evaluation Of Transition From Inhaled Treprostinil To Oral Selexipag

被引：0
|
作者：
Frost, A. [1 ]
Benza, R. L. [2 ]
Farber, H. [3 ]
Kim, N. H. [4 ]
Hartline, B. K. [5 ]
Pfister, T. [6 ]
Shiraga, Y. [6 ]
McLaughlin, V. [7 ]
机构：
[1] Houston Methodist Lung Ctr, Houston, TX USA
[2] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[3] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA
[4] Univ Calif San Diego, Pulm & Crit Care Med, San Diego, CA 92103 USA
[5] Actel Pharmaceut US Inc, San Francisco, CA USA
[6] Actel Pharmaceut Ltd, Allschwil, Switzerland
[7] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3977
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study
    Frost, Adaani
    Janmohamed, Munir
    Fritz, Jason S.
    McConnell, John W.
    Poch, David
    Fortin, Terry Ann
    Miller, Chad E. g
    Chin, Kelly M.
    Fisher, Micah
    Eggert, Michael
    McEvoy, Colleen
    Benza, Raymond L.
    Farber, Harrison W.
    Kim, Nick H.
    Pfister, Thomas
    Shiraga, Yoko
    McLaughlin, Vallerie
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (01): : 43 - 50
  • [2] Tolerability And Safety Of Transition From Inhaled Treprostinil To Oral Selexipag In Pulmonary Arterial Hypertension: Results From The Transit-1 Study
    Frost, A. E.
    Janmohamed, M.
    Fritz, J.
    McConnell, J. W.
    Poch, D.
    Fortin, T.
    Miller, C.
    Chin, K.
    Fisher, M. R.
    Eggert, M.
    McEvoy, C.
    Benza, R. L.
    Farber, H. W.
    Kim, N. H.
    Hartline, B.
    Pfister, T.
    Shiraga, Y.
    McLaughlin, V.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Successful Transition From Oral Selexipag to Treprostinil
    Pham, A.
    Techasatian, W.
    Devendra, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [4] Transition From Inhaled Treprostinil to Selexipag in Pulmonary Arterial Hypertension
    El-Kersh, Karim
    Smith, J. Shaun
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E620 - E621
  • [5] Successful Outpatient Transition from Intravenous Treprostinil to Oral Selexipag
    Kimmig, L. M.
    Bag, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Pulmonary Vasodilator Activity of Inhaled Treprostinil Palmitil, Inhaled Treprostinil, Intravenous Treprostinil and Oral Selexipag in Hypoxia-Challenged Rats
    Corboz, M. R.
    Plaunt, A. J.
    Malinin, V.
    Li, Z.
    Gauani, H.
    Chun, D.
    Cipolla, D.
    Perkins, W.
    Chapman, R. W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] TRANSITION FROM SELEXIPAG TO ORAL TREPROSTINIL IN A PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
    Patel, Amol
    Safdar, Zeenat
    [J]. CHEST, 2018, 154 (04) : 1023A - 1024A
  • [8] Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension
    Oriaku, Ifeoma
    Patel, Amol
    Safdar, Zeenat
    [J]. PULMONARY CIRCULATION, 2020, 10 (01)
  • [9] Transition From Oral Treprostinil to Selexipag in a Patient With Pulmonary Arterial Hypertension
    Verlinden, Nathan J.
    Walter, Claire
    Kanwar, Manreet
    Raina, Amresh
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (07) : 764 - 765
  • [10] From Oral Selexipag to Parenteral Treprostinil; A Two Week Transition Protocol
    Devlin, Sarah
    Minnock, Caitriona
    Moran, Diane
    McCullagh, Brian
    Gaine, Sean
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S500 - S500
12345